These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6585546)

  • 1. Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.
    Colburn WA
    J Pharm Sci; 1984 Mar; 73(3):313-7. PubMed ID: 6585546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.
    Semmes RL; Shen DD
    Drug Metab Dispos; 1990; 18(1):80-7. PubMed ID: 1970782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.
    Tse FL; Ballard F; Skinn J
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):455-61. PubMed ID: 7153875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
    Cotler S; Chen S; Macasieb T; Colburn WA
    Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
    Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
    Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling.
    Toshimoto K; Tomoda Y; Chiba K; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2727-2738. PubMed ID: 28479365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect modelling for drugs undergoing enterohepatic circulation.
    Höglund P; Ohlin M
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):333-8. PubMed ID: 8020531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.
    Colburn WA; Vane FM; Bugge CJ; Carter DE; Bressler R; Ehmann CW
    Drug Metab Dispos; 1985; 13(3):327-32. PubMed ID: 2861992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and biopharmaceutic parameters during enterohepatic circulation of drugs.
    Colburn WA
    J Pharm Sci; 1982 Jan; 71(1):131-3. PubMed ID: 7057372
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of isotretinoin following a single oral dose.
    Khoo KC; Reik D; Colburn WA
    J Clin Pharmacol; 1982; 22(8-9):395-402. PubMed ID: 6957421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study.
    Shepard TA; Gannaway DJ; Lockwood GF
    J Pharm Sci; 1985 Dec; 74(12):1331-3. PubMed ID: 4087202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of drugs subject to enterohepatic circulation.
    Chen HS; Gross JF
    J Pharm Sci; 1979 Jun; 68(6):792-4. PubMed ID: 458586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmentally continuous input functions in linear multicompartment systems.
    Süverkrüp R
    J Pharm Sci; 1985 Feb; 74(2):136-41. PubMed ID: 3989681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.
    Shou M; Lu W; Kari PH; Xiang C; Liang Y; Lu P; Cui D; Emary WB; Michel KB; Adelsberger JK; Brunner JE; Rodrigues AD
    Eur J Pharm Sci; 2005 Oct; 26(2):151-61. PubMed ID: 16085400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical method for monitoring drug excretion and enterohepatic circulation in the rat.
    Tse FL; Ballard F; Jaffe JM
    J Pharmacol Methods; 1982 Mar; 7(2):139-44. PubMed ID: 7098496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of the biliary excretion of drugs in the human].
    Siegers CP; Klaassen CD
    Dtsch Med Wochenschr; 1983 Oct; 108(41):1564-70. PubMed ID: 6352227
    [No Abstract]   [Full Text] [Related]  

  • 19. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.
    Steimer JL; Plusquellec Y; Guillaume A; Boisvieux JF
    J Pharm Sci; 1982 Mar; 71(3):297-302. PubMed ID: 7069584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excretion of drugs in bile in man].
    Terhaag B
    Pharmazie; 1980; 35(10):638-9. PubMed ID: 7454747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.